KTTA Research and Charts

KTTA - Pasithea Therapeutics Corp (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-06-30)

Last 0.72	Change ⇓ -0.04 (0.00%)	Volume 181,152
	Open 0.70	High 0.75	Low 0.70

8EMA (Daily) 0.75	40EMA (Daily) 0.93	50EMA (Daily) 0.99	STO (Daily) 10.985	MACD Hist (Daily) 0.010
8EMA (Weekly) 0.868	40EMA (Weekly) 1.99	50EMA (Weekly) 2.24	STO (Weekly) 1.513	MACD Hist (Weekly) 0.071


Company Profile
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.